MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,397,000 | +95.4% | 20,000 | +310.5% | 0.08% | +211.5% |
Q4 2021 | $715,000 | -73.1% | 4,872 | -67.5% | 0.03% | -67.9% |
Q3 2021 | $2,654,000 | -58.4% | 15,000 | -62.0% | 0.08% | -59.3% |
Q2 2021 | $6,384,000 | +23.2% | 39,522 | +30.7% | 0.20% | +34.5% |
Q1 2021 | $5,180,000 | +135.9% | 30,242 | +202.4% | 0.15% | +85.0% |
Q4 2020 | $2,196,000 | -43.6% | 10,000 | -80.0% | 0.08% | -88.0% |
Q3 2019 | $3,896,000 | +65.4% | 50,000 | 0.0% | 0.67% | +34.5% |
Q3 2018 | $2,355,000 | – | 50,000 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |